STAAR Surgical Company (NASDAQ:STAA) Q4 2019 Earnings Conference Call - Final Transcript

Feb 26, 2020 • 04:30 pm ET

Previous

STAAR Surgical Company (NASDAQ:STAA) Q4 2019 Earnings Conference Call - Final Transcript

Share
Close

Loading Event

Loading Transcript

Presentation
Executive
Deborah Andrews

$0.12 per diluted share as compared to adjusted net income for the year-ago quarter of $3.2 million or $0.07 per diluted share. A table reconciling the GAAP information to the non-GAAP information is included in today's financial release.

Turning now to our balance sheet, our cash, cash equivalents and restricted cash at January 3, 2020, totaled $120 million compared with $104 million at the end of the year-ago fourth quarter. The Company generated a record $25.8 million in cash from operating activities for the full year 2019.

This concludes our prepared remarks. Operator, we're ready to take questions.